James Geraghty
@jamesgeraghty
Director
Building Voyager Therapeutics, Inc. as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Voyager Therapeutics, Inc. was founded in 2013 and has no closure on record.
Named alongside
- Alan EzekowitzDirector
- Amit HasijaExecutive Officer
- Bryan StuartExecutive Officer
- Diego CadavidExecutive Officer
- James CollinsDirector
- James TananbaumDirector
- Kate HavilandDirector
- Katina DortonDirector
- Ann DeWittDirector
- David SchechterDirector
- Eric FurfineExecutive Officer, Director
- Eric RowinskyDirector
- John EdwardsExecutive Officer, Director
- Valerie FriedmanDirector
- Yaniv BejeranoExecutive Officer, Director
- Alfred SandrockExecutive Officer, Director
- Catherine A. MackeyDirector
- George A. ScangosDirector
- Glenn A. PierceDirector
- Grace A. ColonDirector
- Jacquelyn Fahey SandellExecutive Officer
- James A. GeraghtyDirector
- Jude A. OnyiaDirector
Contribution
James's ideas, decisions and failures appear here once this profile is claimed.
Companies
- Voyager Therapeutics, Inc.Biological Products, (No Diagnostic Substances); listed on Nasdaq as VYGR; filing with the SEC since 2015Director · Biotechnology · CAMBRIDGE, United States · Founded 2013
- ImmuneXcite, Inc.Director · Biotechnology · Lexington, United States
- Fulcrum Therapeutics, Inc.Pharmaceutical Preparations; listed on Nasdaq as FULC; filing with the SEC since 2016Director · Biotechnology · CAMBRIDGE, United States · Founded 2015